Vaccines

What You Need To Know About Lyme Disease

Posted on November 14, 2022 in Vaccines

Lyme Disease is one of the most common diseases transmitted by an insect bite in the United States. After a tick attaches itself to a host, it can take up to 24-36 hours for the tick to infect the body with Lyme disease. Once infected, people will usually start having flu-like symptoms such as headaches, […]

HPV

Posted on January 27, 2020 in Vaccines

HPV or Human Papillomavirus Infection is the most common sexually transmitted infection in the United States, according to the CDC. Currently, there is no cure for HPV. Rochester Clinical Research is currently conducting a research study with the FDA approved vaccine Gardasil. This study will help prove that Gardasil not only prevents genital warts and cervical cancer, but also head and neck cancers caused by the same HPV virus.

Chikungunya: A Mosquito Spread Disease

Posted on December 20, 2019 in Vaccines

Did you know mosquitoes can transmit diseases like malaria, dengue, West Nile virus, and chikungunya? Rochester Clinical Research is currently on the forefront of developing one of the first chikungunya vaccines this winter.

Rochester is at the forefront of developing new E. coli vaccine

Posted on October 23, 2019 in Vaccines

Rochester is at the forefront of developing new E. coli vaccine

Antibiotic-Resistant Strains Posing Life-Threatening E. Coli Infections. This vaccine may cover several of those strains.

Ebola Vaccine Now Used in Africa

Posted on August 7, 2019 in Vaccines

Rochester Clinical Research conducted an Ebola Vaccine Research study that is currently being used in Africa. It has been 99% effective for those who have gotten the vaccine.

Smallpox Vaccine Needed for Risk of Bioterrorism

Posted on April 29, 2019 in General Vaccines

Routine vaccinations for smallpox ended 40 years ago after the World Health Organization officially declared global eradication of smallpox. This means the majority of the population is not protected. The threat of bioterrorism and natural re-emergence has prompted the US and countries around the world to prepare an updated vaccine which is more effective and easier to store. RCR is currently on the forefront of developing this vaccine.